Spotlight on Glycolysis: A New Target for Cord Blood Expansion

Andrea M. Patterson, Louis Pelus

Research output: Contribution to journalShort survey

1 Citation (Scopus)

Abstract

Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB. Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB.

Original languageEnglish (US)
Pages (from-to)792-793
Number of pages2
JournalCell Stem Cell
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Glycolysis
Hematopoietic Stem Cells
Fetal Blood
Transplantation
Medicine

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Cite this

Spotlight on Glycolysis : A New Target for Cord Blood Expansion. / Patterson, Andrea M.; Pelus, Louis.

In: Cell Stem Cell, Vol. 22, No. 6, 01.06.2018, p. 792-793.

Research output: Contribution to journalShort survey

Patterson, Andrea M. ; Pelus, Louis. / Spotlight on Glycolysis : A New Target for Cord Blood Expansion. In: Cell Stem Cell. 2018 ; Vol. 22, No. 6. pp. 792-793.
@article{f700cb5cd03845f7b83c496830284768,
title = "Spotlight on Glycolysis: A New Target for Cord Blood Expansion",
abstract = "Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB. Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB.",
author = "Patterson, {Andrea M.} and Louis Pelus",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.stem.2018.04.023",
language = "English (US)",
volume = "22",
pages = "792--793",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Spotlight on Glycolysis

T2 - A New Target for Cord Blood Expansion

AU - Patterson, Andrea M.

AU - Pelus, Louis

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB. Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB.

AB - Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB. Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB.

UR - http://www.scopus.com/inward/record.url?scp=85046690487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046690487&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2018.04.023

DO - 10.1016/j.stem.2018.04.023

M3 - Short survey

C2 - 29859169

AN - SCOPUS:85046690487

VL - 22

SP - 792

EP - 793

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 6

ER -